Editor’s note: this article was published in the Aug. 1, 2024 issue of Pharmaceutical Technology Europe®
Separation and Purification Columns
News
Article
Pharmaceutical TechnologyPharmaceutical Technology, August 2024
Volume 48
Issue 8
These columns offer fast run times, optimal separation efficiency, and reliable results.
Thermo’s DNAPac RP HPLC columns | Image Credit: Thermo Fisher Scientific
The Thermo Scientific SurePac Bio 550 SEC MDi columns enable fast separations of adeno-associated virus (AAV) monomers and aggregates. The columns are designed with 3 µm monodisperse particles and inert (MDi) column hardware aimed at providing superior AAV monomer retention and higher resolution of aggregates in cell and gene therapies.
These columns offer fast run times, optimal separation efficiency, and reliable results with the goal of accelerating time-to-market for novel therapeutics. In addition, Thermo’s DNAPac RP HPLC columns (pictured here) are offered in semi-preparative formats to enable scalability in the development of DNA/RNA oligonucleotides. The DNAPac RP semi-preparative columns are designed so that laboratories can navigate the expanding field of oligonucleotide therapies and precision medicine. The DNAPac RP semi-preparative column utilizes unique chemistry for enhanced performance across wide ranges of pH, temperature, and mobile-phase compositions, offering precise separations and sample purification.
Articles in this issue
Integrating Strategies for Formulation Success
The Role of Dry (Water-free) Process Equipment Cleaning in Continuous Pharmaceutical Manufacturing
Automating Development of Small-Molecule APIs
Considering Process Scaling for Monoclonal Antibodies During Early Phase Development
Considerations for Finished Product Inspection Systems
Germany Amends and Approves the New Medical Research Act
Contracting Out Frees Sponsors Up
Frontrunners in Automated Cell and Gene Therapy Manufacturing
Igniting Pharma’s Potential?
Demanding Impartiality
Going Green: Updating Your Filings
Dual Shaft Mixers with Multi-Agitator System
Next-Generation Tablet Press
New Protein Production Platform
Separation and Purification Columns
Recent Videos
Related Content
Market Demands and Emerging Technologies Shape Outsourcing Models
June 5th 2025Article
Trends in certain forms of drug delivery, as well as the emergence of artificial intelligence, are playing roles in evolving the nature of partnerships, but there are new types of partnerships gaining steam as well.
Drug Solutions Podcast: Novel Drug Delivery Approaches: Refining AAV Vector Deliveries
May 30th 2025Podcast
In this podcast episode, we discuss novel approaches to drug delivery, specifically regarding adeno-associated virus (AAV) vectors, as viewed by two industry experts who recently exhibited at the annual ASGCT meeting.
Transformations in Drug Development for Cell and Gene Therapies
March 28th 2025Podcast
As a recognized leader in immunophenotyping for clinical trials, Kevin Lang from PPD discusses how spectral flow cytometry is transforming drug development, particularly in cell and gene therapies like CAR-T. He also dives into his award-winning research, including his 2024 WRIB Poster Award-winning work, and his insights from presenting at AAPS PharmSci360.
The Role of On-Demand Manufacturing and Derisking in Accelerating Early Clinical Trial Success
June 4th 2025Article
Small pharmaceutical companies are constantly seeking innovative solutions to streamline early clinical trials. Adaptive clinical trials offer important benefits to sponsors and patients, both from a commercial and ethical standpoint. These trials offer flexibility and efficiency, especially in the early stages, where trial protocols can be adjusted based on interim data, such as introducing new doses or modifying participant sample size. However, adjusting manufacturing demand during an adaptive trial can be complicated, and strict regulatory requirements present significant challenges. On-demand manufacturing provides a robust solution, allowing for real-time supply and demand adjustments and improved trial flexibility. This paper explores how on-demand manufacturing meets the operational needs of adaptive trials and aligns with regulatory expectations.
